missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ACSBG2 (aa 559-635) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (61%), Rat (61%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60359 (PA5-60359. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Catalyzes the conversion of fatty acids such as long chain and very long-chain fatty acids to their active form acyl-CoAs for both synthesis of cellular lipids, and degradation via beta-oxidation. Can activate diverse saturated, monosaturated and polyunsaturated fatty acids (PubMed:16371355, PubMed:16762313). Has increased ability to activate oleic and linoleic acid (PubMed:16371355). May play a role in spermatogenesis (PubMed:15685348). [UniProt]
Specifications
Specifications
| Accession Number | Q5FVE4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 81616 |
| Name | Human ACSBG2 (aa 559-635) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | ACSBG2; Acyl-CoA synthetase bubblegum family member 2; Arachidonate--CoA ligase ACSBG2; BGR; BRGL; bubblegum-related protein; Long-chain-fatty-acid--CoA ligase ACSBG2; PRTDNY3; PRTD-NY3; testicular tissue protein Li 8; UNQ2443/PRO5005 |
| Common Name | ACSBG2 |
| Show More |